144 related articles for article (PubMed ID: 32058707)
1. Biophysical Techniques for Distinguishing Ligand Binding Modes in Cytochrome P450 Monooxygenases.
Podgorski MN; Harbort JS; Coleman T; Stok JE; Yorke JA; Wong LL; Bruning JB; Bernhardt PV; De Voss JJ; Harmer JR; Bell SG
Biochemistry; 2020 Mar; 59(9):1038-1050. PubMed ID: 32058707
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the requirements for efficient and selective cytochrome P450 monooxygenase catalysis across different reactions.
Podgorski MN; Coleman T; Chao RR; De Voss JJ; Bruning JB; Bell SG
J Inorg Biochem; 2020 Feb; 203():110913. PubMed ID: 31759265
[TBL] [Abstract][Full Text] [Related]
3. To Be, or Not to Be, an Inhibitor: A Comparison of Azole Interactions with and Oxidation by a Cytochrome P450 Enzyme.
Podgorski MN; Coleman T; Giang PD; Wang CR; Bruning JB; Bernhardt PV; De Voss JJ; Bell SG
Inorg Chem; 2022 Jan; 61(1):236-245. PubMed ID: 34910500
[TBL] [Abstract][Full Text] [Related]
4. The importance of the benzoic acid carboxylate moiety for substrate recognition by CYP199A4 from Rhodopseudomonas palustris HaA2.
Coleman T; Chao RR; De Voss JJ; Bell SG
Biochim Biophys Acta; 2016 Jun; 1864(6):667-675. PubMed ID: 26969786
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the substrate range of CYP199A4: modification of the partition between hydroxylation and desaturation activities by substrate and protein engineering.
Bell SG; Zhou R; Yang W; Tan AB; Gentleman AS; Wong LL; Zhou W
Chemistry; 2012 Dec; 18(52):16677-88. PubMed ID: 23135838
[TBL] [Abstract][Full Text] [Related]
6. The binding of nitrogen-donor ligands to the ferric and ferrous forms of cytochrome P450 enzymes.
Mohamed H; Ghith A; Bell SG
J Inorg Biochem; 2023 May; 242():112168. PubMed ID: 36870164
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450-catalyzed oxidation of halogen-containing substrates.
Coleman T; Podgorski MN; Doyle ML; Scaffidi-Muta JM; Campbell EC; Bruning JB; De Voss JJ; Bell SG
J Inorg Biochem; 2023 Jul; 244():112234. PubMed ID: 37116269
[TBL] [Abstract][Full Text] [Related]
8. The crystal structures of 4-methoxybenzoate bound CYP199A2 and CYP199A4: structural changes on substrate binding and the identification of an anion binding site.
Bell SG; Yang W; Tan AB; Zhou R; Johnson EO; Zhang A; Zhou W; Rao Z; Wong LL
Dalton Trans; 2012 Jul; 41(28):8703-14. PubMed ID: 22695988
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of CYP199A2, a para-substituted benzoic acid oxidizing cytochrome P450 from Rhodopseudomonas palustris.
Bell SG; Xu F; Forward I; Bartlam M; Rao Z; Wong LL
J Mol Biol; 2008 Nov; 383(3):561-74. PubMed ID: 18762195
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of the heme aqua-ligand coordination environment in an engineered peroxygenase cytochrome P450 variant.
Podgorski MN; Lee JHZ; Harbort JS; Nguyen GTH; Doherty DZ; Donald WA; Harmer JR; Bruning JB; Bell SG
J Inorg Biochem; 2023 Dec; 249():112391. PubMed ID: 37837941
[TBL] [Abstract][Full Text] [Related]
11. Selective oxidative demethylation of veratric acid to vanillic acid by CYP199A4 from Rhodopseudomonas palustris HaA2.
Bell SG; Tan AB; Johnson EO; Wong LL
Mol Biosyst; 2010 Jan; 6(1):206-14. PubMed ID: 20024082
[TBL] [Abstract][Full Text] [Related]
12. Enabling Aromatic Hydroxylation in a Cytochrome P450 Monooxygenase Enzyme through Protein Engineering.
Coleman T; Lee JZH; Kirk AM; Doherty DZ; Podgorski MN; Pinidiya DK; Bruning JB; De Voss JJ; Krenske EH; Bell SG
Chemistry; 2022 Dec; 28(67):e202201895. PubMed ID: 36043399
[TBL] [Abstract][Full Text] [Related]
13. A single mutation in cytochrome P450 BM3 induces the conformational rearrangement seen upon substrate binding in the wild-type enzyme.
Joyce MG; Girvan HM; Munro AW; Leys D
J Biol Chem; 2004 May; 279(22):23287-93. PubMed ID: 15020590
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
15. 4-cyanopyridine, a versatile spectroscopic probe for cytochrome P450 BM3.
Ost TW; Clark JP; Anderson JL; Yellowlees LJ; Daff S; Chapman SK
J Biol Chem; 2004 Nov; 279(47):48876-82. PubMed ID: 15364917
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of distinct ligand binding sites for cytochrome P450 3A4.
Hosea NA; Miller GP; Guengerich FP
Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664
[TBL] [Abstract][Full Text] [Related]
17. Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common.
Locuson CW; Hutzler JM; Tracy TS
Drug Metab Dispos; 2007 Apr; 35(4):614-22. PubMed ID: 17251307
[TBL] [Abstract][Full Text] [Related]
18. Resonance Raman investigations of Escherichia coli-expressed Pseudomonas putida cytochrome P450 and P420.
Wells AV; Li P; Champion PM; Martinis SA; Sligar SG
Biochemistry; 1992 May; 31(18):4384-93. PubMed ID: 1581294
[TBL] [Abstract][Full Text] [Related]
19. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
[TBL] [Abstract][Full Text] [Related]
20. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
